NIH-funded research NIH-funded research

APOE variants and Alzheimer’s disease: uncovering protective mechanisms

Official title: Biology and Pathobiology of APOE in Aging and Alzheimer's Disease 2.0

Funded at Mayo Clinic Jacksonville · NIH-11418796 · Data updated 2026-11-12

A large NIH-funded effort at Mayo Clinic Jacksonville is studying how different forms of APOE may protect against Alzheimer’s disease and age-related memory problems, with the goal of guiding new therapies.

More s Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville
NIH-funded
Lab location1 site (Jacksonville, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2031
Funding year2026
Award (this year)$4,639,242
NIH project number2U19AG069701-06
Project IDNIH-11418796 on NIH RePORTER

Who could benefit from this research

Could help

Patients with or at risk for Alzheimer’s disease or age-related cognitive decline may benefit from future therapies developed from these findings.

Less likely to help

People without Alzheimer’s risk factors or those not studying APOE-related biology may not directly benefit.

What this research studies

This project brings together scientists from several institutions to explore how APOE variants influence brain health as we age. Researchers will examine the structure, chemistry, and interactions of protective APOE variants and how they alter processes like lipid transport and cell signaling. The work aims to connect these molecular insights to why some people develop Alzheimer’s dementia later in life and how we might prevent it. By combining laboratory experiments with analyses of human biology, the team hopes to identify targets for therapies that reduce age-related cognitive decline.

Why it matters

Potential benefit: It could lead to new strategies to prevent or slow Alzheimer's-related memory problems by targeting APOE-related pathways.

How similar studies have gone: Prior research has shown APOE variants influence AD risk, with ongoing work validating protective mechanisms.

Where this research is happening

  • Mayo Clinic Jacksonville
    Jacksonville, United States
    Active

Researchers

  • Principal investigator: Kanekiyo, Takahisa — Mayo Clinic Jacksonville
  • Study coordinator: Kanekiyo, Takahisa

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.